United States of America Anticoagulants Market Size and Trends
The United States of America anticoagulants market refers to therapies that inhibit blood coagulation to prevent life-threatening conditions like stroke, deep vein thrombosis, and pulmonary embolism. Landscape is defined by a decisive transition from traditional vitamin K antagonists toward Direct Oral Anticoagulants (DOACs), which offer more predictable pharmacological profiles.